"Heptanoic Acids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
7-carbon saturated monocarboxylic acids.
| Descriptor ID |
D006538
|
| MeSH Number(s) |
D10.251.450
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Heptanoic Acids".
Below are MeSH descriptors whose meaning is more specific than "Heptanoic Acids".
This graph shows the total number of publications written about "Heptanoic Acids" by people in this website by year, and whether "Heptanoic Acids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 2 | 0 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Heptanoic Acids" by people in Profiles.
-
Crespo MJ, Cruz N, Quidgley J, Torres H, Hernandez C, Casiano H, Rivera K. Daily administration of atorvastatin and simvastatin for one week improves cardiac function in type 1 diabetic rats. Pharmacology. 2014; 93(1-2):84-91.
-
El-Bagary RI, Elkady EF, El-Sherif ZA, Kadry AM. LC-MS-MS simultaneous determination of atorvastatin and ezetimibe in human plasma. J Chromatogr Sci. 2014 Sep; 52(8):773-80.
-
Wilson NO, Solomon W, Anderson L, Patrickson J, Pitts S, Bond V, Liu M, Stiles JK. Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria. PLoS One. 2013; 8(4):e60898.
-
Iwata A, Miura S, Tanaka T, Ike A, Sugihara M, Nishikawa H, Kawamura A, Saku K. Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin. Coron Artery Dis. 2012 Aug; 23(5):315-21.
-
Bereal-Williams C, Machado RF, McGowan V, Chi A, Hunter CJ, Kato GJ, Hunter L, Dalby CK, Hauser KP, Tailor A, Cannon RO. Atorvastatin reduces serum cholesterol and triglycerides with limited improvement in vascular function in adults with sickle cell anemia. Haematologica. 2012 Nov; 97(11):1768-70.
-
Date AA, Nagarsenker MS. Novel delivery systems of atorvastatin should be evaluated for pharmacodynamics instead of pharmacokinetics. J Pharm Pharmacol. 2007 Nov; 59(11):1583-4.
-
Mitsutake R, Miura S, Okamura K, Niimura H, Kawamura A, Saku K. Successful intensive lipid-lowering therapy using atorvastatin stabilizes coronary artery plaque as assessed by multi-detector row computed tomography. Intern Med. 2007; 46(12):859-63.
-
Crespo MJ, Quidgley JA. Statins decrease serotonin-induced contractions in coronary arteries of swine in vitro. Pharmacology. 2006; 76(3):141-7.
-
Ghayour-Mobarhan M, Lamb DJ, Taylor A, Vaidya N, Livingstone C, Wang T, Ferns GA. Effect of statin therapy on serum trace element status in dyslipidaemic subjects. J Trace Elem Med Biol. 2005; 19(1):61-7.
-
Brandle M, Davidson MB, Schriger DL, Lorber B, Herman WH. Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes. Diabetes Care. 2003 Jun; 26(6):1796-801.